Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Ascendis Pharma ( (ASND) ).
On April 14, 2026, Ascendis Pharma’s board granted 32,310 warrants to certain employees, each entitling the holder to subscribe for one ordinary share at an exercise price of $249.84, matching the closing price of its American Depositary Shares on the grant date. The awards, which vest over four years with an initial cliff after one year and accelerated vesting upon specified exit events, are part of the company’s long-term incentive program and leave warrants for an additional 1,611,843 shares available for future grants, potentially expanding the equity base and further aligning employee compensation with shareholder value.
The most recent analyst rating on (ASND) stock is a Buy with a $292.00 price target. To see the full list of analyst forecasts on Ascendis Pharma stock, see the ASND Stock Forecast page.
Spark’s Take on ASND Stock
According to Spark, TipRanks’ AI Analyst, ASND is a Neutral.
The score is driven primarily by improving fundamentals (rapid revenue growth, strong margins, and a move to positive operating/free cash flow) but is held back by balance-sheet risk (negative equity and high debt) and unprofitable earnings (negative P/E). Technicals are neutral-to-slightly cautious, while the latest earnings call adds support via upbeat guidance and commercial/pipeline momentum despite elevated operating expenses and near-term volatility risks.
To see Spark’s full report on ASND stock, click here.
More about Ascendis Pharma
Ascendis Pharma A/S is a Denmark-based biopharmaceutical company focused on developing, manufacturing and commercializing medical preparations for combating diseases. The company also holds shares in businesses with similar objectives and may engage in related activities, with its ordinary shares represented in the U.S. via American Depositary Shares.
Average Trading Volume: 674,263
Technical Sentiment Signal: Buy
Current Market Cap: $14.84B
For an in-depth examination of ASND stock, go to TipRanks’ Overview page.